Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
scd-101 (1 trial)
Anemia, Sickle Cell (Phase 1)
Thalassemia (Phase 1)
Trials (1 total)
Trial APIs (1 total)